JPMorgan Trims Afya Price Target to $21.50, Maintains Neutral Rating

Key Facts

JPMorgan Chase & Co. has adjusted its investment outlook for Afya, lowering its price target from $22.00 to $21.50. Despite the slight reduction, the bank maintained its "Neutral" rating on the stock. The revised target still implies a significant potential upside of 49.20% relative to the stock's current market price. This stands in contrast to the broader market consensus, where analysts hold an average price target of $17.20 and a collective "Hold" rating. The adjustment by JPMorgan reflects a minor downward revision in valuation expectations while remaining cautious on the equity's near-term momentum. Investors are closely watching whether the stock can bridge the gap toward these institutional valuation targets.